Mechanically elongated neuronal cells

ABSTRACT

Mechanically elongated neuronal cells and methods of mechanically producing elongated cells are provided. Also provided are methods for transplanting elongated neuronal cells into an animal for treatment of spinal cord injuries and other nerve injuries.

This application claims the benefit of provisional U.S. application Ser.No. 60/149,408, filed Aug. 17, 1999.

INTRODUCTION

This invention was supported in part by funds from the U.S. government(NIH Grant No. AG12527) and the U.S. government may therefore havecertain rights in the invention.

BACKGROUND OF THE INVENTION

In the United States, approximately 12,000 people each year suffer someform of spinal cord injury (SCI), with over 200,000 people chronicallyparalyzed from SCI. Current therapy for SCI includes surgery, drugtreatment and prolonged rehabilitation. However, due to the extensiveloss of neural tissue and the poor regenerative capacity of such tissue,the success of current therapy has been limited. The injury of concernis the loss of continuity of bi-directional nerve signals between thebrain and the extremities. In most SCIs, the lesioned region of thespinal cord reaches several centimeters in length. Therefore, naturalreconnection in these cases is an extremely unlikely event.

Methods for transplantation of neural tissue into the area of the SCI inorder to reduce the deficits associated with the injury and to promotefunctional recovery are currently under development. In animal studies,embryonic tissue transplants into the areas of a lesioned spinal cordhave been shown to survive and to reinnervate certain regions of thespinal cord (Bjorklund et al. 1986. Neuroscience 18:685-698; Buchananand Nornes. 1986. Brain Res. 381:225-236; Moorman et al. 1990. BrainRes. 508:194-198; Ribotta et al. 1996. Brain Res. 707:245-255). Suchstudies have shown that the time of transplant after injury and the typeof cell transplanted affects the success of the attempted transplant.These transplant studies have focused on reinstating nerve fiberconnections using ex vivo donor material or attempting to grow longnerve fibers by attractant molecules. However, neither approach totransplantation has had success in growing nerve fibers over a distanceof more than a few millimeters.

A variety of methods have been used as a way to bridge or fill spinalcord injury lesions that include transplanting peripheral nerves,transplanting intact fetal spinal cords, transplanting progenitor cells,transplanting stem cells, or transplanting dissociated cells fromnervous tissue (McDonald, J. W. 1999. Sci. Amer. 281:64-73; Zompa, E. A.et al. 1997. J. Neurotrauma 14:479-506). Some of these techniques haveresulted in improved functional outcome in animal models of spinal cordinjury. However, improved function has not been attributed directly tothe reinstatement of spinal cord signals through the transplant. Rather,it has been proposed that the primary benefit of the transplanted tissuein these models is through physical and biochemical support for the hosttissue surrounding the lesion (Stichel, C. C. and H. W. Muller. 1998.Prog. Neurobiol. 56:119-148; Anderson, D. K. et al. 1995. Brain Pathol.5:451-457). While the results of these studies have been promising, thegoal of re-establishing an axonal connection through a spinal cordlesion has yet to be realized.

Studies have shown that short-term tension on single axon growth conesfrom chick sensory neurons resulted in “towed growth” (Bray, D. 1984.Develop. Neurobiol. 102:379-389; Lamoureux, P. et al. 1989. Nature340:159-162; Zheng, J. et al. 1991. J. Neurosci. 11:1117-1125). Thoughpoorly understood, it is believed that this growth mechanism commonlyoccurs in synapsed CNS axons during embryogenesis and development. Sincetracts of synapsed axons have no growth cones from which to extend tomatch the growth of an organism. Axon elongation must occur fromreorganizing and building onto the center length of the axon. It ispossible that continuous tensile forces along axons trigger this growthin length.

Elongation of cells used for transplant would therefore be advantageous.Studies with other types of cells have shown that mechanical methods canbe used to stretch cells. For example, research on human endothelialcells has shown that mechanical stretching of these cells results inchanges in cell orientation and size, as well as cell morphology andfunction (Yano et al. 1997. J. Cell. Biochem. 64:505-513; Shirinsky etal. 1989. J. Cell Biol. 109:331-339; Galbraith et al. 1998. Cell Motil.Cytoskel. 40:317-330). In one study, mechanical stretching of neuronalcells demonstrated the high tolerance of these cells to dynamic stretchinjury (Smith et al. 1999. J. Neurosci. 19:4263-4269). The focus ofstudies on elongation of cells through mechanical stretching, however,has been on the degree of stretch that can be tolerated before cellslose function or the ability to recover from injury and possible use ofthese cells in a cell injury model.

It has now been found that mechanically stretched neuronal cells can beproduced and used to reconnect damaged spinal cord tissue and reinstateflow of nerve signals.

SUMMARY OF THE INVENTION

An object of the present invention is to provide compositions comprisingmechanically elongated neuronal cells.

Another object of the present invention is to provide a method forproducing elongated cells which comprises culturing selected cells,plating said cultured cells onto an overlying membrane and an underlyingmembrane so that said cultured cells cover both membranes, and movingthe overlying membrane across the underlying membrane via a motor-drivenmovement so that the cultured cells are mechanically stretched and splitinto two populations connected by elongated cells.

In a preferred embodiment, this method is performed on neuronal cellssuch as N-tera2 cells.

Yet another object of the present invention is to provide a method fortreating nerve injury which comprises transplanting elongated neuronalcells into the nerve of an animal suffering from a nerve at the site ofinjury. This method would include treatment of spinal cord injury.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 provides a diagram of the process of axonal “stretch-inducedgrowth”. In the top picture, a short membrane attached to an aluminumblock is placed on top of a long rectangular membrane. These structuresare enclosed in a Plexiglas box with a gas exchange port (not shown). Achamber is formed by the aluminum block in which mammalian CNS neuronsare plated and allowed to integrate over 3 days. A neural network isformed, including axons that grow across the border between the top andbottom membranes. In the bottom picture, movement of the aluminum blockis depicted via a computer controlled microstepper motor system thatdivides the culture and progressively separates the opposing halves bysliding the top membrane across the bottom membrane at a step-rate of3.5 micrometers every 5 minutes. This technique results in thestretch-induced growth of fascicular tracts of axons spanning the twomembranes.

FIG. 2 depicts phase photomicrographs demonstrating stretch-inducedgrowth of integrated CNS axons. The same region of a progressivelyexpanding live culture is shown at 2 days (top), 4 days (middle) and 7days (bottom) of elongation. At each end are the parent and targetneurons adhering to the bottom membrane (right) and top membrane (left).Spanning these neurons are large bundles of progressively elongated axontracts. Bar represents 1 mm.

FIG. 3 depicts phase photomicrographs of one region of stretch-grownaxons at the border of the top membrane at 2 days (left), 4 days(middle) and 7 days (right) of elongation. Note the gradual joining ofneighboring axon bundles and thickening of the bundles at the edge ofthe top membrane. Bar represents 50 microns.

FIG. 4 depicts representative fluorescence photomicrographs of axontracts at 7 days of stretch-induced growth, elucidated by immunostainedmicrotuble protein in fixed cultures. On the left are multiple longfascicular axon tracts arranged in parallel that were produced bystretch-induced growth (bar=50 microns). On the right is a slightlyenlarged view of a large 40 micron fascicular axon tract demonstrating asubstantial network of microtubules.

DETAILED DESCRIPTION OF THE INVENTION

The primary functional constituents of the spinal cord are myelinatedaxons and neurons. Signals travel from brain to body and back via theseaxons which synapse to spinal neurons communicating with the targetedbody region. Paralysis develops when the bi-directional signaling isinterrupted due to axon damage which severs communication below the siteof injury. A key to recovery from such injury would be axonaltransplantation. However, axons, which grow out of neurons and then areguided to adjacent neuronal cells by chemical attractants, have not beenable to be grown over the distances required for SCI, distances ofcentimeters rather than millimeters.

A mechanical device has now been developed to elongate neuronal cells sothat two populations of neurons can be connected by stretching axonalcells over distances not possible with other prior art methods. Althoughprevious studies have shown that axons exhibit short-term tolerance tostrain or stretching, the ability of axonal cells to tolerate long-termstretch and then to elongate successfully and remain viable has notpreviously been shown.

To elongate cells, an enclosed cell culture system was developed whichcomprises a plexiglass box with a removable lid and glass bottom and agas exchange port. On the inside base, a long rectangular absorbablemembrane (substrate; Lactosorb, BioMet, Inc., Warsaw Ind.) for neuronattachment was fixed in place. The biologically absorbable material waschosen as it is more compatible for transplantation into tissue. Anothershorter membrane was placed on top leaving an exposed region of theunderlying membrane near one end (see FIG. 1). This overlying membranewas fixed to a movable bar that was driven by two steel rods. Movementof the overlying membrane across the underlying membrane was performedby activation of a motor-table assembly (Servo Systems, Inc., Montville,N.J.) and microstepper motors (Pacific Scientific, Rockford, Ill.).Control of the movements was computer driven using a linear table(Aerotech, Irvine, Calif.), an encoder (Remco Encoders, Inc., Goleta,Calif.) and an indexer/driver (Panther, Intelligent Motor Systems,Marlborough, Conn.; QuickStep II Driver Software).

Any cells can be elongated with this device. By “elongated cells” it ismeant cells that have been modified so that they have an increasedlength as compared to cells that have not been stretched with the methodof the present invention. In a preferred embodiment of the presentinvention, the device is used to produce compositions comprisingelongated neurons. In addition to the elongated cells, the compositionsmay further comprise culture media and selected growth factors. Neuronsto be elongated can be derived from various animal sources, includinghumans, and isolated via filtration. Alternatively, neuronal cell linessuch as the N-tera2 cell line can be elongated. Using this device, ithas been shown that the axons or neurons can be elongated to greaterthan 0.2 cm after one day of stretching and greater than 1 cm after 5days of stretching.

The ability of this device to elongate neurons was demonstrated usingthe N-tera2 cell line and primary rat neurons. Cells (approximately 10million) were plated over the outside border of the overlying andunderlying membrane. The cells remained in culture for three to sevendays to allow time for adherence of neurons to the membrane and for thegrowth of nerve fibers (axons and dendrites), forming a network betweenthe neurons. Accordingly, a single neuron network was established thatcovered both the overlying and underlying membranes. The driver of thedevice was then activated and the stepper motors moved the top(overlying) membrane across the underlying membrane at speeds of 3.5 to7 μm every 5 minutes or 1 to 2 mm/day (see FIG. 1). The movement of themembrane split the neuron culture into two populations, bridged bybundles of axons (see FIG. 2). The axons readily adapted to the stretcheven to distances of over one centimeter (see FIGS. 3 and 4).

Using the step rate of 3.5 μm per 5 minutes to progressively movefurther apart the two halves that had been formed with stretching, itwas found that few of no neuronal somata were present in the expandingcenter region. However, bridging this expanding center region werenumerous large bundles of axoms, 3 to 40 μm in diameter. These bundlesoriginated from fascicular tracts of axons that had crossed the dividingline between the underlying and overlying membranes prior to separation.While these tracts had random directional orientations prior tostretching with the method of the instant invention, the axon bundlescrossing the expanding gap gradually assumed straight orientationsarranged in parallel (see FIG. 4). These bridging axons appeared toreadily adapt to stretch event though they had increased their originallength or 100 to 200 μm to become longer than 7 mm over 7 days ofstretch-growth. These bridging axons grew in girth as well as in length.In particular, the hillocks of the axon bundles at the edges of theneuronal populations became wider during elongation (see FIG. 3). Inaddition to general thickening, there was a joining together ofneighboring axon bundles during stretch-growth. Thus, there wereprogressively fewer but much broader fasicular tracts of axons bridgingthe two populations of neurons. With the typical diameter of the axonsat less than 1 μm, the larger bundles were estimated to contain morethan 1000 axons. Despite the relatively rapid stretch-growth of theseaxons, when the flasks containing the cells were agitated, lateralmovement of the axon bundles was observed, indicating that thereremained some slack in the axon bundles and that the center portion ofthe axon bundles was not attached to the membranes. The regions of thebundles nearest the ends of the gaps, however, did appear to adhere tothe underlying membrane.

These results are the first demonstration of substantial progressivegrowth of large tracts of synapsed CNS axons in response to a continuousmechanical tension. Further, these data show for the first time thatmechanically elongating axon bundles consolidate into larger tracts.Moreover, the elongated axon/neuron cultures remained sufficientlyviable for use as transplant material. Although these studies wereterminated at 7 days of stretch-growth, these was no indication thatfurther elongation could not be achieved with longer times ofstretch-growth.

Doubling of the elongation speed from 3.5 μm/5 minutes to 7 μm/5 minutesled to an almost total obliteration of the axon bundles, with only a fewremaining that spanned the gap at 3 days of stretch. Therefore, there isa limit to the tolerance of long-term stretch in terms of the rate ofstretch, which is lower than the tolerance previously reported forshort-term elongation of single axons towed from their growth cones.

Compositions comprising elongated neuronal cells of the presentinvention are useful as a source of transplant material for patientswith SCI as well as other nerve lesions. Methods for transplantation ofthe cells produced by the method of the instant invention are well knownto those of skill in the art of cell transplantation.

In one embodiment, mechanically elongated neurons are implanted at bothends of a lesion proximate to viable cells so that the implanted cellscan replace nerve function and reconnect nerves of the individual toremedy or otherwise ameliorate the injury. The neurons are implanted ina location that allows processes which develop therefrom to substitutefor the processes of the damaged nerve, thereby repairing the damagednerve network. Thus, as used herein, the term “at or near a site of saidnerve damage” is meant to refer to the location where nerve cells areimplanted in order to replace destroyed, damaged or dysfunctional nervecells and/or restore function resulting from destroyed, damaged ordysfunctional nerve cells. The location is defined as being a site wheresuch implanted cells can develop as replacement cells for destroyed,damaged or dysfunctional nerve cells and make the necessary linkages torestore function lost due to destroyed, damaged or dysfunctional nervecells.

A transplant strategy is to match the length of the stretched axoncultures with the length of the spinal cord lesion. Transplant wouldproceed by placing the membrane with the cultured cells into the lesionso that neurons at both ends of the axon bundles are in proximity toviable tissue at the end margins of the spinal cord lesion. In additionto spinal cord repair, the transplant material can be used as a bridgefor other types of neural injuries, including optic nerve damage andperipheral nerve damage. Transplant of elongated axons for peripheralnerve damage repair may be most optimal due to the more permissiveneural growth environment in the peripheral nervous system compared withthe CNS.

The capacity of grafted elongated neurons to promote axonal regenerationand functional recovery in vivo can be demonstrated using an animalmodel of spinal cord injury. For example, adult rats can be surgicallyanesthetized and prepared for aseptic surgery. For these studies, ratsare first trained in the “staircase test” to assess forepaw functionprior to receiving a C3-C4 laminectomy and cervical cord hemisection,which causes loss of function in one upper limb. Immediately followingthe hemisection, into one group of animals is transplanted a membranewith the elongated axons stretched to the length of the lesion. Themembrane with the elongated axons stretched to the length of the lesionis then transplanted so that the neuron populations at each end of themembrane are inserted into viable tissue at each end of the lesion. Thesecond group of animals is left untreated as controls.

Beginning at one week post-transplant, the dorsal spinal cord isexamined electrophysiologically to determine whether communicationbetween proximal and distal regions of the lesion had beenre-established.

Skilled forelimb function is also assessed using a staircase apparatusconsisting of a plastic box with built-in left and right staircases withfive steps each. The staircases are separated from each other in such amanner that it is impossible for an animal to reach the right staircasewith any limb other than the right forelimb and vice versa. The fivesteps on each staircase are loaded with small food pellets, and theanimals are allowed to acquire as many food pellets as possible usingeach forelimb independently in a 15 minute period. The number of pelletsconsumed by the rat are counted at the end of each test period andrecorded as “number of pellets taken”. Each animal is assessed in thestaircase test preoperatively and at 1-, 4- and 8-weeks post-implant. At8-weeks post-implant, animals are sacrificed and sections of the spinalcord are processed for serotonin (5-HT) immunohistochemistry to identifydescending serotonergic fibers.

Similar transplant procedures can be performed in humans. For example,N-Tera2 cells are currently being evaluated for transplantation into thebrain in human stroke patients. Prior to transplant, it is preferable todiagnose location and presence of any damage to the spinal cord and thevolume of the damage by MRI and CT. Neuronal cells for implant areelongated as discussed above. It is preferred that a volume of cellsequal to that of the damaged regions of the spinal cord be elongated.The surgeon then locates the appropriate level(s) of the spine andaccesses the spinal canal to remove the damaged regions and other debriswhich might block nerve regeneration, using known techniques. Next thesurgeon places the membrane of elongated neuronal cells into this regionso that the elongated axons bridge the length of the lesion and theneuron populations at each end of the membrane are inserted into viabletissue at each end of the lesion. Next the layers surrounding the spinalcord are closed, as are the more superficial layers. In circumstances ofthe acute application of this technique following trauma,methylprednisolone is administered at the beginning of the surgery inthe usual spinal injury dose and is continued for as long as the surgeonconsiders necessary, which may vary from 1 week to several months. Incircumstances in which the cells are histocompatible with the recipient,or other situations under the physician's determination, anti-rejectiontherapy may not be needed.

The following nonlimiting examples are provided to further illustratethe present invention.

EXAMPLES Example 1

Cell Culture

The N-tera2 cell line was selected because of the well-characterizedability of this cell line to differentiate into robust human neurons(Pleasure et al. 1992. J. Neurosci. 12:1802-1815; Pleasure, S. J. andLee, V. M. J. 1993. J. Neurosci. Res. 35:585-602). In addition, thiscell line has been shown to respond to excitatory injury in a mannersimilar to that of primary neuronal cell cultures (Munir et al. 1995. J.Neurosci. 15:7847-7860). The NT2 cells were maintained in culture withOptiMEM (Life Technologies, Gaithersburg, Md.) media supplemented with5% fetal bovine serum (FBS; HyClone, Logan, Utah) and 1%penicillin-streptomycin (Pen-Strep; Life Technologies). To differentiatethe NT2 cells into neurons (NT2N), the NT2 cells were cultured for 5weeks in DMEM supplemented with 10% FBS (HyClone), antibiotics (1%PenStrep; Life Technologies), and 10 μM retinoic acid (Sigma, St. Louis,Mo.). To isolate neurons in the culture, the cells were trypsinized,triturated with a fire-polished Pasteur pipette, and replated in DMEMsupplemented with 5% FBS and mitotic inhibitors (10 μM5-fluoro-2′-deoxyuridine, 10 μM uridine, and 1 μM cytosineβ-arabino-furanoside; Sigma) for 9 days. The cells remaining after thisprocedure have been determined to be 99% neuronal. The NT2N neurons wereseeded on the absorbable membrane of the device and cultures weremaintained in conditioned media (50% media from the first replate and50% DMEM with 5% FBS).

Example 2

Microscopic Examination of Elongated Cells

Phase microscopy and photomicrography were performed on a Nikon Diaphotmicroscope with a Nikon 8008 camera. Confocal microscopy was performedwith a Zeiss LSM5 (Heidelberg, Germany). Deconvolution microscopy asdescribed by Hiraoka et al. 1987. Science 238:36-41 was performed on aZeiss Axiovert 100 microscope equipped with a cooled CCD (PrincetonInstruments (Trenton, N.J.) and DeltaVision constrained iterativedeconvolution software (Applied Precision, Issaquah, Wash.).

What is claimed is:
 1. A composition comprising integrated elongatedneuronal cells resulting from ex vivo machine-driven, physicalstretching of already synapsed neurons maintained in culture.
 2. Thecomposition of claim 1 wherein axons of the neuronal cells are elongatedto greater than 0.2 cm.
 3. The composition of claim 1 wherein axons ofthe neuronal cells are elongated to greater than 1 cm.